Announcing a new white paper, "Lupus Community Panel Proposals for Optimizing Clinical Trials: 2018," developed to address critical issues that have stymied the lupus drug development process for decades.
The Omnibus Appropriations bill passed by the US House of Representatives on March 22 includes increased funding for critical lupus research and education programs.
Leslie Tierney, our V.P. of Operations / Patient Navigator, and a registered nurse sat down as a guest and talked with Alive & Well regarding a more holistic understanding of Lupus and the individuals it affects.
The Lupus Foundation of America announces the election of two new board members, Andrew Brophy and Barbara Polk.
Results from a Phase IIb 24-week clinical trial show that Atacicect is safe and may benefit people with high levels of disease activity.
The collaboration between Exagen and GSK will raise awareness of Exagen's AVISE diagnostic and monitoring tests among healthcare professionals around the world.
Researchers at Cincinnati Children’s Hospital Medical Center are looking for young adults age 18 to 30 that have skin lupus or SLE-CL to participate in the study of an investigational drug.
During cold weather, symptoms of Raynaud’s phenomenon tend to strike people with lupus. Find out how other people with lupus cope with this painful condition.